ODYY-Main.png
Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug
29 juin 2022 08h30 HE | Odyssey Health, Inc
Las Vegas, NV, June 29, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...
190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
25 juin 2022 10h02 HE | BioNTech SE
Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels;...
intrommune_icon_500x500.png
Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy
22 juin 2022 09h31 HE | Intrommune Therapeutics
Amendment to Extend Study Duration to 48 weeks New Maintenance Period Is Designed to Evaluate Safety of INT301 After Long-term Exposure NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Intrommune...
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
17 juin 2022 09h22 HE | BioNTech SE
In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 Vaccine elicited a strong immune response in this age group Three 3-µg doses had favorable safety profile similar to placebo in young...
Pfizer und BioNTech erhalten FDA-Notfallzulassung für ihren COVID-19-Impfstoff bei Kindern im Alter von 6 Monaten bis 4 Jahren
17 juin 2022 09h22 HE | BioNTech SE
Daten einer klinischen Phase-2/3-Studie zeigten, dass der Pfizer-BioNTech COVID-19-Impfstoff in dieser Altersgruppe eine starke Immunantwort auslöstDie Impfserie mit drei 3-µg-Dosen bei Kindern im...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TOP RANKED FIRM, Encourages Verrica Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – VRCA
11 juin 2022 15h16 HE | The Rosen Law Firm PA
NEW YORK, June 11, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
Straits Research Pvt Ltd
PET Packaging Market is projected to reach USD 100 Billion by 2030, growing at a CAGR of 5%: Straits Research
09 juin 2022 12h45 HE | Straits Research
New York, United States, June 09, 2022 (GLOBE NEWSWIRE) -- PET is a type of polyester that is also called polyethylene terephthalate. It's ejected or molded into plastic bottles and boxes for the...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPRO
05 juin 2022 17h15 HE | The Rosen Law Firm PA
NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Spero...
Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design
01 juin 2022 09h00 HE | Recardio Inc.
SAN FRANCISCO, June 01, 2022 (GLOBE NEWSWIRE) -- Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin along with data suggesting potential positive...
Logo.png
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz®
24 mai 2022 11h29 HE | Biofrontera Inc.
WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, views new data on skin...